Impact of neoadjuvant chemotherapy on pathological stage and survival in sarcomatoid bladder cancer.

被引：0
|
作者：
Roy, Arya Mariam [1 ]
Jatwani, Karan [1 ]
Kumarasamy, Vasanthan Muthusamy [1 ]
Perimbeti, Stuthi [1 ]
Jiang, Changchuan [1 ]
Gupta, Kush [1 ]
Guru, Khurshid [1 ]
Chatta, Gurkamal S. [1 ]
Gopalakrishnan, Dharmesh [1 ]
机构：
[1] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
530
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The evolution of neoadjuvant immunotherapy in bladder cancer.
    Galsky, Matthew D.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12) : 4 - 4
  • [32] NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN MUSCLE-INVASIVE BLADDER CANCER: EVALUATING THE PATHOLOGICAL RESPONSE AND SURVIVAL OUTCOMES IN OCTOGENARIANS
    Avudaiappan, Arjun Pon
    Prabhakar, Pushan
    Ajabshir, Daniel
    Eldefrawy, Ahmed
    Caso, Jorge
    Garje, Rohan
    Manoharan, Murugesan
    JOURNAL OF UROLOGY, 2024, 211 (05): : E867 - E867
  • [33] Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival
    Patel, Hiten D.
    Patel, Sunil H.
    Blanco-Martinez, Enrique
    Kuzbel, Jake
    Chen, Victor S.
    Druck, Aleksander
    Koehne, Elizabeth L.
    Patel, Parth M.
    Doshi, Chirag P.
    Hahn, Noah M.
    Hoffman-Censits, Jean H.
    Berg, Stephanie
    Bivalacqua, Trinity J.
    Kates, Max
    Quek, Marcus L.
    JOURNAL OF UROLOGY, 2022, 207 (01): : 77 - 85
  • [34] Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer
    Liu, Libo
    Xu, Longhao
    Wu, Daqin
    Zhu, Yingying
    Li, Xiaoyang
    Xu, Chunru
    Chen, Ke
    Lin, Yi
    Lao, Jianwen
    Cai, Peicong
    Li, Xuesong
    Luo, Yun
    Li, Xiang
    Huang, Jian
    Lin, Tianxin
    Zhong, Wenlong
    EBIOMEDICINE, 2024, 104
  • [35] The effect of chemotherapy on overall survival of stage II colon cancer.
    Omaira, M.
    Mozayen, M.
    Katato, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [36] Impact of chemotherapy on survival for low risk versus high risk early stage ovarian cancer.
    Occhiogrosso, Rachel Hope
    Steinhoff, Margaret
    Has, Phinnara
    Raker, Christina
    DiSilvestro, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] A POST-CHEMOTHERAPY RESTAGING EVALUATION IMPROVES THE CORRELATION OF CLINICAL AND PATHOLOGICAL STAGE IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY AND RADICAL CYSTECTOMY FOR BLADDER CANCER
    Reese, Adam
    Ball, Mark
    Bivalacqua, Trinity
    Netto, George
    Schoenberg, Mark
    JOURNAL OF UROLOGY, 2013, 189 (04): : E769 - E769
  • [38] Effect of clinical stage on survival outcome in patients with pathological stage I gastric cancer.
    Tokunaga, Masanori
    Makuuchi, Rie
    Miki, Yuichiro
    Tanizawa, Yutaka
    Bando, Etsuro
    Kawamura, Taiichi
    Terashima, Masanori
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [39] GENE MODULES AND PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER. A POOLED ANALYSIS
    Ignatiadis, M.
    Singhal, S. K.
    Desmedt, C.
    Haibe-Kains, B.
    Criscitiello, C.
    Andre, F.
    Loi, S.
    Piccart, M.
    Michiels, S.
    Sotiriou, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 17 - 17
  • [40] NEOADJUVANT CHEMOTHERAPY IN UNRESECTABLE COLON CANCER.
    Verstegen, M.
    Gooyer, J.
    't Lam-Boer, J.
    Radema, S.
    Elfrink, M.
    Verhoef, C.
    Schreinemakers, J.
    de Wilt, J.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E250 - E250
12345